Moderna's Key Patent Win Overshadowed By Gloomy Outlook

benzinga.com/markets/earnings/25/08/46791309/modernas-key-patent-win-overshadowed-by-gloomy-outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.
The COVID-19 vaccine maker reported quarterly sales of $142 million, beating the consensus of $116.34…

This story appeared on benzinga.com, 2025-08-01 12:44:55.
The Entire Business World on a Single Page. Free to Use →